
CAS 301356-95-6
:CID5721353
Description:
CID 5721353, also known by its CAS number 301356-95-6, is a chemical compound that belongs to the class of small molecules. It is characterized by its specific molecular structure, which includes various functional groups that contribute to its chemical reactivity and biological activity. This compound has been studied for its potential applications in medicinal chemistry, particularly in the development of therapeutic agents. Its properties may include solubility in organic solvents, stability under certain conditions, and specific interactions with biological targets. The compound's molecular weight, boiling point, melting point, and other physical properties are determined by its unique structure. Additionally, CID 5721353 may exhibit specific pharmacological effects, making it of interest in drug discovery and development. As with any chemical substance, safety data and handling precautions are essential for its use in laboratory and industrial settings. Further research is often necessary to fully understand its mechanisms of action and potential applications in various fields.
Formula:C15H9BrN2O6S2
Synonyms:- CID-5721353;CID 5721353
- 79-6 (CID5721353, BCL6 inhibitor)
- Butanedioic acid, 2-[5-(5-bromo-1,2-dihydro-2-oxo-3H-indol-3-ylidene)-4-oxo-2-thioxo-3-thiazolidinyl]-
- CID5721353
- CID5721353, BCL6 inhibitor
- 2-(5-(5-bromo-2-oxoindolin-3-ylidene)-4-oxo-2-thioxothiazolidin-3-yl)succinic acid
- BCL6 inhibitor(CID5721353)
- CID 5721353;CID-5721353;CID 5721353
- BCL6 inhibitor
- CID5721353 BDL6 inhribitor
Sort by
Purity (%)
0
100
|
0
|
50
|
90
|
95
|
100
Found 4 products.
CID5721353
CAS:CID5721353 disrupts BCL6/corepressor complexes, binds critical BTB groove site in vitro/vivo.Formula:C15H9BrN2O6S2Purity:98.90%Color and Shape:SolidMolecular weight:457.28Ref: TM-T3940
2mg35.00€5mg50.00€10mg84.00€25mg140.00€50mg221.00€100mg331.00€200mg472.00€1mL*10mM (DMSO)52.00€CID5721353
CAS:CID5721353 is a protein inhibitor that inhibits the enzyme ubiquitin ligases. It binds to the hydroxyl group of lysine residues on target proteins, which prevents the formation of poly-ubiquitin chains. This inhibition leads to irreversible inhibition of these enzymes and can be used in vivo to treat autoimmune diseases and HIV infection. CID5721353 has been shown to have cell-specific activity, inhibiting only activated T cells in lymphomas.Formula:C15H9BrN2O6S2Purity:Min. 95%Molecular weight:457.28 g/mol



